Developing New Drugs for Diabetes and Cardiometabolic Disorders: A Changing Paradigm

Author： Krentz Andrew J.   Morrow Linda   Hompesch Marcus  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.13, 2012-09, pp. : 1709-1711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2189-2200

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness

By  

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3317-3324

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 743-756

Bentham Science Publishers

Access to resources Recommend Favorite

New Drugs for HDL-C Disorders: The Beginning

By  

Current Medicinal Chemistry, Vol. 21, Iss. 25, 2014-08 ,pp. : 2947-2951

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus

By  

Current Drug Discovery Technologies, Vol. 4, Iss. 1, 2007-01 ,pp. : 39-47

Bentham Science Publishers

Access to resources Recommend Favorite